The acute course of COVID-19 is variable and ranges from asymptomatic infection to fulminant
respiratory failure. Patients recovering from COVID-19 can have persistent symptoms and …

Background Multidrug-resistant tuberculosis (MDR-TB) is associated with substantial morbidity,
despite drug therapy. Interferon-γ, a cytokine produced mainly by CD4 T lymphocytes, …

Pulmonary tuberculosis may alter volatile organic compounds (VOCs) in breath because
Mycobacteria and oxidative stress resulting from Mycobacterial infection both generate …

Study objectives To investigate the characteristics of tuberculosis infection in diabetic patients
at Bellevue Hospital. Design We conducted a case-control study retrospectively reviewing …

We investigated the in vivo effect of coinfection of Mycobacterium tuberculosis on human
immunodeficiency virus type 1 (HIV-1) replication using bronchoalveolar lavage (BAL) of 11 HIV…

Many patients with obstructive sleep apnea syndrome (OSAS), despite therapy with nasal
continuous positive airway pressure (CPAP), have persisting daytime somnolence that may be …

Local cellular immune responses may affect presentation and outcome in tuberculosis (TB).
To investigate this hypothesis, we performed bronchoalveolar lavage (BAL) on 30 patients …

Progressive fibrosing interstitial lung disease (PF-ILD) has been redefined as a new clinical
syndrome that shares similar genetics, pathophysiology, and natural history to idiopathic …

Background Current treatment regimens for pulmonary tuberculosis require at least 6 months
of therapy. Immune adjuvant therapy with recombinant interferon-γ1b (rIFN-γb) may reduce …

Background: Inhaled interferon-γ aerosol (aINF-γ) may be effective treatment for idiopathic
pulmonary fibrosis (IPF). We evaluated safety and delivery of aIFN-γ (100 μg 3 times/week) in …